TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New tuberculosis study findings reported from S.K. Katiyar and co-authors
November 18th, 2008
"To assess the potential use of Quanti-FERON-TB Gold In-Tube (R) (QFT-G) in monitoring clinical response to anti-tuberculosis treatment. We conducted a cohort study of 76 active pulmonary tuberculosis patients with serial testing by QFT-G at baseline and after 2 and 6 months of treatment," scientists in the United States report. "At these time points, we compared the performance of QFT-G with sputum culture status of the study subjects. Compared to baseline, 59 (77.6%) cases showed a decline whereas 17 (22.4%) showed persistent or stronger interferon-gamma (IFN-gamma) responses at 2 months. Using robust statistical methods, we observed that QFT-G assessment at 2 months...
Source: TB & Outbreaks Week (2008-11-18)
|
